Terms: = Colorectal cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Clinical Outcome
3 results:
1. Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients.
Winder T; Zhang W; Yang D; Ning Y; Bohanes P; Gerger A; Wilson PM; Pohl A; Mauro DJ; Langer C; Rowinsky EK; Lenz HJ
Clin Cancer Res; 2010 Nov; 16(22):5591-602. PubMed ID: 20935157
[TBL] [Abstract] [Full Text] [Related]
2. NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer.
Puvvada SD; Funkhouser WK; Greene K; Deal A; Chu H; Baldwin AS; Tepper JE; O'Neil BH
Oncology; 2010; 78(3-4):181-8. PubMed ID: 20414006
[TBL] [Abstract] [Full Text] [Related]
3. A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases.
Ogino S; Nosho K; Irahara N; Kure S; Shima K; Baba Y; Toyoda S; Chen L; Giovannucci EL; Meyerhardt JA; Fuchs CS
Clin Cancer Res; 2009 Jul; 15(13):4431-8. PubMed ID: 19549773
[TBL] [Abstract] [Full Text] [Related]
